BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17371989)

  • 21. Reflections on the state of play in somatic hypermutation.
    Steele EJ
    Mol Immunol; 2008 May; 45(10):2723-6. PubMed ID: 18359085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Better living with hyper-mutation.
    Goodman MF
    Environ Mol Mutagen; 2016 Jul; 57(6):421-34. PubMed ID: 27273795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
    Komori A; Xu Z; Wu X; Zan H; Casali P
    Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
    Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region.
    Pan-Hammarström Q; Dai S; Zhao Y; van Dijk-Härd IF; Gatti RA; Børresen-Dale AL; Hammarström L
    J Immunol; 2003 Apr; 170(7):3707-16. PubMed ID: 12646636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nucleotide targets of somatic mutation and the role of selection in immunoglobulin heavy chains of a teleost fish.
    Yang F; Waldbieser GC; Lobb CJ
    J Immunol; 2006 Feb; 176(3):1655-67. PubMed ID: 16424195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Model of Somatic Hypermutation Targeting in Mice Based on High-Throughput Ig Sequencing Data.
    Cui A; Di Niro R; Vander Heiden JA; Briggs AW; Adams K; Gilbert T; O'Connor KC; Vigneault F; Shlomchik MJ; Kleinstein SH
    J Immunol; 2016 Nov; 197(9):3566-3574. PubMed ID: 27707999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
    Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
    Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting.
    Longo NS; Lugar PL; Yavuz S; Zhang W; Krijger PH; Russ DE; Jima DD; Dave SS; Grammer AC; Lipsky PE
    Blood; 2009 Apr; 113(16):3706-15. PubMed ID: 19023113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlapping hotspots in CDRs are critical sites for V region diversification.
    Wei L; Chahwan R; Wang S; Wang X; Pham PT; Goodman MF; Bergman A; Scharff MD; MacCarthy T
    Proc Natl Acad Sci U S A; 2015 Feb; 112(7):E728-37. PubMed ID: 25646473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation.
    Zheng NY; Wilson K; Jared M; Wilson PC
    J Exp Med; 2005 May; 201(9):1467-78. PubMed ID: 15867095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Ig gene somatic hypermutation in the absence of activation-induced cytidine deaminase.
    Longo NS; Satorius CL; Plebani A; Durandy A; Lipsky PE
    J Immunol; 2008 Jul; 181(2):1299-306. PubMed ID: 18606684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stabilised DNA secondary structures with increasing transcription localise hypermutable bases for somatic hypermutation in IGHV3-23.
    Duvvuri B; Duvvuri VR; Wu J; Wu GE
    Immunogenetics; 2012 Jul; 64(7):481-96. PubMed ID: 22391874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deoxyuridine is generated preferentially in the nontranscribed strand of DNA from cells expressing activation-induced cytidine deaminase.
    Martomo SA; Fu D; Yang WW; Joshi NS; Gearhart PJ
    J Immunol; 2005 Jun; 174(12):7787-91. PubMed ID: 15944282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A source of the single-stranded DNA substrate for activation-induced deaminase during somatic hypermutation.
    Wang X; Fan M; Kalis S; Wei L; Scharff MD
    Nat Commun; 2014 Jun; 5():4137. PubMed ID: 24923561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targets of somatic hypermutation within immunoglobulin light chain genes in zebrafish.
    Marianes AE; Zimmerman AM
    Immunology; 2011 Feb; 132(2):240-55. PubMed ID: 21070232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA-binding motifs of hnRNP K are critical for induction of antibody diversification by activation-induced cytidine deaminase.
    Yin Z; Kobayashi M; Hu W; Higashi K; Begum NA; Kurokawa K; Honjo T
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11624-11635. PubMed ID: 32385154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled.
    Shen HM; Storb U
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12997-3002. PubMed ID: 15328407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nurse shark T-cell receptors employ somatic hypermutation preferentially to alter alpha/delta variable segments associated with alpha constant region.
    Ott JA; Harrison J; Flajnik MF; Criscitiello MF
    Eur J Immunol; 2020 Sep; 50(9):1307-1320. PubMed ID: 32346855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.